Literature DB >> 28899198

Adaptive immune constraints on C. difficile vaccination.

Mark L Lang1, Binu Shrestha1.   

Abstract

Entities:  

Keywords:  C. difficile; antibody; immune memory; polysaccharide; toxin

Mesh：

Substances：

Year:  2017        PMID： 28899198      PMCID： PMC6072257          DOI： 10.1080/14760584.2017.1379397

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  20 in total

Review 1.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

2.  International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.

Authors:  Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; V Avesani; Michelle M Merrigan; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.

Authors:  Guy de Bruyn; Jamshid Saleh; David Workman; Richard Pollak; Victor Elinoff; Neil J Fraser; Gigi Lefebvre; Mark Martens; Richard E Mills; Richard Nathan; Miguel Trevino; Martin van Cleeff; Ginamarie Foglia; Ayca Ozol-Godfrey; Dhaval M Patel; Patricia J Pietrobon; Richard Gesser
Journal:  Vaccine       Date:  2016-03-21       Impact factor: 3.641

Review 4.  Carbohydrate-Based Vaccines: An Overview.

Authors:  Julia Hütter; Bernd Lepenies
Journal:  Methods Mol Biol       Date:  2015

Review 5.  Carbohydrate-based Clostridium difficile vaccines.

Authors:  Mario A Monteiro; Zuchao Ma; Lisa Bertolo; Yuening Jiao; Luis Arroyo; Douglas Hodgins; Michael Mallozzi; Gayatri Vedantam; Martin Sagermann; John Sundsmo; Herbert Chow
Journal:  Expert Rev Vaccines       Date:  2013-04       Impact factor: 5.217

6.  Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.

Authors:  T Scott Devera; Gillian A Lang; Jordi M Lanis; Pragya Rampuria; Casey L Gilmore; Judith A James; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2015-10-26       Impact factor: 3.441

7.  Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers.

Authors:  Nicole Bézay; Andrea Ayad; Katrin Dubischar; Christa Firbas; Romana Hochreiter; Sigrid Kiermayr; István Kiss; Fritz Pinl; Bernd Jilma; Kerstin Westritschnig
Journal:  Vaccine       Date:  2016-04-11       Impact factor: 3.641

8.  Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.

Authors:  Tanya M Monaghan; Adrian Robins; Alan Knox; Herbert F Sewell; Yashwant R Mahida
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

9.  Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.

Authors:  C Eckert; A Emirian; A Le Monnier; L Cathala; H De Montclos; J Goret; P Berger; A Petit; A De Chevigny; H Jean-Pierre; B Nebbad; S Camiade; R Meckenstock; V Lalande; H Marchandin; F Barbut
Journal:  New Microbes New Infect       Date:  2014-11-08

10.  Toxin B is essential for virulence of Clostridium difficile.

Authors:  Dena Lyras; Jennifer R O'Connor; Pauline M Howarth; Susan P Sambol; Glen P Carter; Tongted Phumoonna; Rachael Poon; Vicki Adams; Gayatri Vedantam; Stuart Johnson; Dale N Gerding; Julian I Rood
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962
View more
  2 in total

Review 1.  Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires.

Authors:  Hemangi B Shah; Kenneth Smith; Jonathan D Wren; Carol F Webb; Jimmy D Ballard; Rebecka L Bourn; Judith A James; Mark L Lang
Journal:  Front Immunol       Date:  2019-01-15       Impact factor: 7.561

2.  Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with Clostridioides difficile Spores.

Authors:  Ana Raquel Maia; Rodrigo Reyes-Ramírez; Marjorie Pizarro-Guajardo; Anella Saggese; Ezio Ricca; Loredana Baccigalupi; Daniel Paredes-Sabja
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.